Nordenskjöld, A., Fohlin, H., Fornander, T., Löfdahl, B., Skoog, L., & Stål, O. (2016). Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer. Breast Cancer Res Treat.

Nordenskjöld, Anna, Helena Fohlin, Tommy Fornander, Britta Löfdahl, Lambert Skoog, and Olle Stål. "Progesterone Receptor Positivity Is a Predictor of Long-term Benefit From Adjuvant Tamoxifen Treatment of Estrogen Receptor Positive Breast Cancer." Breast Cancer Res Treat 2016.

Nordenskjöld, Anna, et al. "Progesterone Receptor Positivity Is a Predictor of Long-term Benefit From Adjuvant Tamoxifen Treatment of Estrogen Receptor Positive Breast Cancer." Breast Cancer Res Treat 2016.